# James L. Pearle, MD – FDA Inspection, Jul 10, 2019

Source: https://www.keypedia.com/records/fda_inspections/james-l-pearle-md/5b353b96-96d3-44e9-88af-911115cc5d44
Source feed: FDA_Inspections

> FDA inspection 1095774 of James L. Pearle, MD, July 10, 2019. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 312. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1095774
- Company Name: James L. Pearle, MD
- Inspection Date: 2019-07-10
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 931851 - 2015-06-11](https://www.keypedia.com/records/fda_inspections/james-l-pearle-md/ccf51c01-9aef-4e34-af37-117107b27853)
- FDA Inspection 706407 - 2011-01-20

## Related Officers

- [Company Rep](https://www.keypedia.com/people/angela-shepas/743113c1-799b-44e9-9422-8049c476bfd2)

Company: https://www.keypedia.com/companies/james-l-pearle-md/28164f5a-3fef-4bfa-b374-1d53b0bc5d45

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
